RevMAb Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Debt - PPP

RevMAb General Information

Description

Owner and operator of a biotechnology company intended to focus on the development of recombinant monoclonal antibodies using a revolutionary technology. The company's antibodies promote personal health by accelerating biomedical research and advancing disease diagnosis without cell fusion and hybridoma generation, enabling clients to get superior monoclonal antibodies easily without generation of hybridoma.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 870 Dubuque Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

RevMAb Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RevMAb Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 05-May-2020 00.000 Completed
2. Angel (individual) 04-Feb-2018 00.000 00.000 Completed Startup
1. Angel (individual) 07-Apr-2016 $4.3M $4.3M Completed Startup
To view RevMAb’s complete valuation and funding history, request access »

RevMAb Executive Team (1)

Name Title Board Seat Contact Info
Yaohuang Ke President, Chief Executive Officer & Board Member
To view RevMAb’s complete executive team members history, request access »

RevMAb Board Members (3)

Name Representing Role Since
Dean Tsao RevMAb Board Member 000 0000
George Lee RevMAb Board Member 000 0000
Yaohuang Ke RevMAb President, Chief Executive Officer & Board Member 000 0000
To view RevMAb’s complete board members history, request access »

RevMAb Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial